Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP

被引:167
作者
Manoury, B
Mazzeo, D
Fugger, L
Viner, N
Ponsford, M
Streeter, H
Mazza, G
Wraith, DC
Watts, C [1 ]
机构
[1] Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Div Cell Biol, Dundee DD1 5EH, Scotland
[2] Aarhus Univ Hosp, Skejby Sygehus, Dept Clin Immunol, DK-8200 Aarhus, Denmark
[3] Univ Bristol, Sch Med Sci, Dept Pathol & Microbiol, Bristol BS8 1TD, Avon, England
基金
英国惠康基金;
关键词
D O I
10.1038/ni754
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Little is known about the processing of putative human autoantigens and why tolerance is established to some T cell epitopes but not others. Here we show that a principal human HLA-DR2-restricted epitope-amino acids 85-99 of myelin basic protein, MBP(85-99)-contains a processing site for the cysteine protease asparagine endopeptidase (AEP). Presentation of this epitope by human antigen-presenting cells is inversely proportional to the amount of cellular AEP activity: inhibition of AEP in living cells greatly enhances presentation of the MBP(85-99) epitope, whereas overexpression of AEP diminishes presentation. These results indicate that central tolerance to this encephalitogenic MBP epitope may not be established because destructive processing limits its display in the thymus. Consistent with this hypothesis, AEP is expressed abundantly in thymic antigen-presenting cells.
引用
收藏
页码:169 / 174
页数:6
相关论文
共 41 条
[1]   High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: Mechanisms of selection of the self-reactive repertoire [J].
Anderson, AC ;
Nicholson, LB ;
Legge, KL ;
Turchin, V ;
Zaghouani, H ;
Kuchroo, VK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (05) :761-770
[2]   Mechanisms of central and peripehral T-cell tolerance: lessons from experimental models of multiple sclerosis [J].
Anderton, S ;
Burkhart, C ;
Metzler, B ;
Wraith, D .
IMMUNOLOGICAL REVIEWS, 1999, 169 :123-137
[3]   Negative selection during the peripheral immune response to antigen [J].
Anderton, SM ;
Radu, CG ;
Lowrey, PA ;
Ward, ES ;
Wraith, DC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (01) :1-11
[4]   Control of antigen presentation by a single protease cleavage site [J].
Antoniou, AN ;
Blackwood, SL ;
Mazzeo, D ;
Watts, C .
IMMUNITY, 2000, 12 (04) :391-398
[5]   Characterization of a recombinant murine 18.5-kDa myelin basic protein [J].
Bates, IR ;
Matharu, P ;
Ishiyama, N ;
Rochon, D ;
Wood, DD ;
Polverini, E ;
Moscarello, MA ;
Viner, NJ ;
Harauz, G .
PROTEIN EXPRESSION AND PURIFICATION, 2000, 20 (02) :285-299
[6]   Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand [J].
Bielekova, B ;
Goodwin, B ;
Richert, N ;
Cortese, I ;
Kondo, T ;
Afshar, G ;
Gran, B ;
Eaton, J ;
Antel, J ;
Frank, JA ;
McFarland, HF ;
Martin, R .
NATURE MEDICINE, 2000, 6 (10) :1167-1175
[7]   Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase [J].
Chen, JM ;
Dando, PM ;
Rawlings, ND ;
Brown, MA ;
Young, NE ;
Stevens, RA ;
Hewitt, E ;
Watts, C ;
Barrett, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (12) :8090-8098
[8]  
DAVIDSON HW, 1990, J IMMUNOL, V144, P4101
[9]   AN AUTOANTIGENIC T-CELL EPITOPE FORMS UNSTABLE COMPLEXES WITH CLASS-II MHC - A NOVEL ROUTE FOR ESCAPE FROM TOLERANCE INDUCTION [J].
FAIRCHILD, PJ ;
WILDGOOSE, R ;
ATHERTON, E ;
WEBB, S ;
WRAITH, DC .
INTERNATIONAL IMMUNOLOGY, 1993, 5 (09) :1151-1158
[10]   Distinct intracellular compartments involved in invariant chain degradation and antigenic peptide loading of major histocompatibility complex (MHC) class II molecules [J].
Ferrari, G ;
Knight, AM ;
Watts, C ;
Pieters, J .
JOURNAL OF CELL BIOLOGY, 1997, 139 (06) :1433-1446